$547 Million is the total value of Boxer Capital, LLC's 26 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | BEIGENE LTDsponsored adr | $58,632,000 | -5.5% | 600,000 | 0.0% | 10.72% | -24.2% | |
| MGNX | MACROGENICS INC | $41,800,000 | +2.8% | 2,200,000 | 0.0% | 7.64% | -17.5% | |
| BPMC | BLUEPRINT MEDICINES CORP | $18,853,000 | +8.2% | 250,000 | 0.0% | 3.45% | -13.1% | |
| KURA | KURA ONCOLOGY INC | $12,925,000 | +2.3% | 844,789 | 0.0% | 2.36% | -17.8% | |
| GTHX | G1 THERAPEUTICS INC | $12,483,000 | -20.3% | 629,179 | 0.0% | 2.28% | -36.0% | |
| CBAY | CYMABAY THERAPEUTICS INC | $9,319,000 | +14.1% | 1,012,986 | 0.0% | 1.70% | -8.4% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $8,608,000 | -7.5% | 267,500 | 0.0% | 1.57% | -25.7% | |
| GTXI | GTX INC DEL | $7,185,000 | +50.6% | 565,291 | 0.0% | 1.31% | +20.9% | |
| BLPH | BELLEROPON THERAPEUTICS INC | $4,791,000 | +81.7% | 1,857,143 | 0.0% | 0.88% | +46.0% | |
| AQXP | AQUINOX PHARMACEUTICALS INC | $3,675,000 | -17.1% | 312,500 | 0.0% | 0.67% | -33.4% | |
| RGLS | REGULUS THERAPEUTICS INC | $2,286,000 | -16.8% | 2,197,802 | 0.0% | 0.42% | -33.1% | |
| SNDX | SYNDAX PHARMACEUTICALS INC | $876,000 | -25.1% | 100,000 | 0.0% | 0.16% | -39.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
| F-star Therapeutics, Inc. | February 14, 2022 | ? | ? |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-14 |
| SC 13D/A | 2024-05-14 |
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.